Canine osteoarthritis (OA) effects up to ~25% of U.S. Dogs (~20 Million)1,2

Severely limiting their quality of life with their families

German Shepherd
grass

The chronic pain of OA is one of the most significant, debilitating conditions in companion animal health3

Enormous opportunity exists to address the untreated population.

~2 million Dogs

are referred to specialists each year4

arrow right

Only ~900K of these actually see a specialist

Only ~600K of these seen are eventually treated

Current therapies can fall short in effectively treating chronic OA.3

icon time

Short-acting—designed for acute pain and inflammation

icon target

Limited effect—only target specific pathway receptors

icon question

Uncertain effectiveness of supplements and unapproved products in treating the chronic pain of OA—limited or no evidence-based data

icon warning

Caution with administration—can be associated with systemic side effects (GI, renal, chondrotoxic)

icon x

Inconvenience or noncompliance—require daily administration or multiple treatments

Elbow OA is an extremely debilitating disorder, afflicting up to 2 million dogs in the US4

  • Medical and surgical management is often unrewarding5
  • Fewer than 50% of all treated dogs have satisfactory long-term recovery5

Elbow OA—A lifetime of debilitating pain

Analgesics are often needed as early as 2 years of age.

Elbow dysplasia often leads to OA in young active dogs and is commonly diagnosed in the most popular breeds.5,6

Labrador Retrievers, Golden Retrievers, German Shepherds and Rottweilers

dog breeds

Pet parents want safe, effective, long-term pain and inflammation relief for their pet that frees them from the stress and worry of daily medicines or time-consuming rehabilitation.

A new treatment is needed for long-term relief from the pain and inflammation of chronic OA

Images are courtesy of Dr. David Dycus, DACVS, Veterinary Orthopedic Sports Medicine Group, Annapolis Junction, MD

chronic OA

Where current therapies are not effective, have long-term safety concerns and surgery is not an option

Dysplastic Joints
Where conservative care would be preferred before more invasive procedures

Synovetin OA™ delivers sustained, long-term OA relief.7

Synovetin OA™ provides targeted, non-systemic therapy.8

References:

  1. American College of Veterinary Surgeons. Osteoarthritis in dogs. Available at: https://www.acvs.org/small-animal/osteoarthritis-in-dogs. Accessed July 8, 2019.
  2. Daily Dog Stuff. US pet ownership statistics 2018/2019. Available at: https://www.dailydogstuff.com/us-pet-ownership-statistics. Accessed July 8, 2019.
  3. Bland SD. Canine osteoarthritis and treatments: a review. Veterinary Science Development. 2015;5(2):84-89. DOI: 10.4081/vsd.2015.5931.
  4. Data on File, Harmony Marketing Partners.
  5. Orthopedic Foundation for Animals. Examining elbow dysplasia. Available at: https://www.vin.com/apputil/content/defaultadv1.aspx?id=3853864&pid=11203&. Accessed 6/28/19.
  6. American College of Veterinary Surgeons. Canine Elbow Dysplasia. Available at: https://www.acvs.org/small-animal/canine-elbow-dysplasia. Accessed 5/15/19.
  7. Data on File, Exubrion Therapeutics.
  8. Fox SM, Donecker JM. Synovitis Technical Bulletin. Exubrion Therapeutics July 2019.